PI Pharma Insight

Incruse Ellipta 55micrograms/dose dry powder inhaler

BNF presentation 0301020T0BBAAAA within chapter Respiratory System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.

Product

Incruse Ellipta

Chemical substance

Umeclidinium bromide

Presentation code

0301020T0BBAAAA

Usage overview

Total items and spend derived from NHS dispensing data.

Items dispensed

120,323

NHS spend (£)

£3,466,236.19

Recent activity

March 2025

Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.

Dispensing trend

Month-by-month national usage.

Month Items dispensed
March 2025 13,194
February 2025 95
December 2024 3,186
November 2024 14,475
October 2024 15,293
September 2024 22
August 2024 1,110
July 2024 16,251
May 2024 2,949
July 2021 8,044
June 2021 5,690
December 2020 18,631

Top pharmacies dispensing this medicine

Identify providers with the highest utilisation to focus engagement and support.

Pharmacy Items Region
Unknown pharmacy 927 No data available
Unknown pharmacy 548 No data available
Castlegate And Derwent Surgery
ODS A82021
417 01H - NORTH EAST AND NORTH CUMBRIA ICB
Pershore Medical Practice
ODS M81074
395 18C - HEREFORDSHIRE & WORCESTERSHIRE ICB
Unknown pharmacy 391 No data available
Unknown pharmacy 382 No data available
Lancaster Medical Practice
ODS P81002
327 01K - LANCASHIRE AND SOUTH CUMBRIA ICB
Modality Partnership (awc)
ODS B83033
326 36J - WEST YORKSHIRE ICB
Stanmore Medical Group
ODS E82005
322 06K - HERTFORDSHIRE AND WEST ESSEX ICB
Unknown pharmacy 313 No data available